727 related articles for article (PubMed ID: 30619328)
1. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
Front Immunol; 2018; 9():2971. PubMed ID: 30619328
[No Abstract] [Full Text] [Related]
2. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E
Front Immunol; 2021; 12():754469. PubMed ID: 34790198
[TBL] [Abstract][Full Text] [Related]
3. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
[TBL] [Abstract][Full Text] [Related]
4. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
[TBL] [Abstract][Full Text] [Related]
5. Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study.
Sciascia S; Radin M; Cecchi I; Rubini E; Scotta A; Rolla R; Montaruli B; Pergolini P; Mengozzi G; Muccini E; Baldovino S; Ferro M; Vaccarino A; Mahler M; Menegatti E; Roccatello D
Front Immunol; 2019; 10():376. PubMed ID: 30891041
[No Abstract] [Full Text] [Related]
6. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
7. Clinical feature and anti-phospholipid antibody profiles of pregnancy failure in young women with antiphospholipid antibody syndrome treated with conventional therapy.
Kaneko K; Mishima S; Goto M; Mitsui M; Tanigaki S; Oku K; Ozawa N; Inoue E; Atsumi T; Sago H; Murashima A
Mod Rheumatol; 2018 Jul; 28(4):670-675. PubMed ID: 29067844
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome.
Zhang S; Wu Z; Zhang W; Zhao J; Norman GL; Zeng X; Zhang F; Li Y
Clin Chem Lab Med; 2018 May; 56(6):939-946. PubMed ID: 29561729
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I.
Sanfelippo MJ; Joshi A; Schwartz S; Meister JA; Goldberg JW
Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738
[TBL] [Abstract][Full Text] [Related]
10. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
[TBL] [Abstract][Full Text] [Related]
11. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
[TBL] [Abstract][Full Text] [Related]
12. 'Non-criteria antiphospholipid antibodies': bridging the gap between seropositive and seronegative antiphospholipid syndrome.
Truglia S; Mancuso S; Capozzi A; Recalchi S; Riitano G; Longo A; De Carolis S; Spinelli FR; Alessandri C; Ceccarelli F; De Carolis C; Misasi R; Sorice M; Conti F
Rheumatology (Oxford); 2022 Feb; 61(2):826-833. PubMed ID: 33970223
[TBL] [Abstract][Full Text] [Related]
13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
14. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
[TBL] [Abstract][Full Text] [Related]
15. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
[TBL] [Abstract][Full Text] [Related]
16. Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome.
Hoxha A; Mattia E; Tonello M; Grava C; Pengo V; Ruffatti A
Clin Chem Lab Med; 2017 May; 55(6):890-898. PubMed ID: 27816952
[TBL] [Abstract][Full Text] [Related]
17. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome.
Vlagea A; Gil A; Cuesta MV; Arribas F; Diez J; Lavilla P; Pascual-Salcedo D
Clin Appl Thromb Hemost; 2013 Jun; 19(3):289-96. PubMed ID: 22387581
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort.
Hu C; Li S; Xie Z; You H; Jiang H; Shi Y; Qi W; Zhao J; Wang Q; Tian X; Li M; Zhao Y; Zeng X
Front Immunol; 2021; 12():741369. PubMed ID: 34567005
[TBL] [Abstract][Full Text] [Related]
19. Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?
Pregnolato F; Chighizola CB; Encabo S; Shums Z; Norman GL; Tripodi A; Chantarangkul V; Bertero T; De Micheli V; Borghi MO; Meroni PL
Immunol Res; 2013 Jul; 56(2-3):432-8. PubMed ID: 23572433
[TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies.
Radin M; Barinotti A; Foddai SG; Cecchi I; Rubini E; Roccatello D; Menegatti E; Sciascia S
Immunol Res; 2021 Aug; 69(4):372-377. PubMed ID: 34245429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
